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Introduction
            As our ability to discover new genetic mutations has increased, the list of inherited 
arrhythmias grows with each year. Virtually every form of arrhythmia has an inherited form, 
whether it is bradycardia, tachycardia or arrhythmic sudden death. This paper will therefore only 
focus   mainly   on   those   that   are   clinically   most   important   in   children.                    
Bradycardia
Sinus   node   disease                                                                              
            Sinus node dysfunction has been described as an inherited (autosomal recessive form) 
problem by Benson et al1. The cause seems to be certain specific mutations on the SCN5A gene. 
Patients with long QT type 3 (SCN5A mutation) have sinus bradycardia as part of the spectrum 
of abnormalities in this disease2. Atrial standstill is a rare condition where the atrium is silent i.e. 
there is no electrical activity present and also the atrium is not excitable by pacing. Rare, 
inherited forms of this condition have been described3,4.                                                         
AV   node   disease                                                                    
            The spectrum of AV block associated with ASD and sudden death has been described 
secondary to mutations in the NKX2.5 gene5. Some patients with Long QT type 3 and others 
with Brugada syndrome (both of which are due to mutations in the SCN5A gene) have 
associated complete heart block (CHB)2-5. Patients with myotonic dystrophy which is inherited 
in auto dominant fashion have CHB. This condition is also associated with cardiomyopathy and 
SCD6.
Tachycardia
    Inherited forms of suprventricular tachycardia (SVT) including ectopic atrial tachycardia, AV 
nodal reentrant tachycardia, WPW syndrome, atrial fibrillation have all been described7-11. 
However,   they   are   rare.   Inherited   ventricular   tachycardia   (VT)   such   as   idiopathic   right 
ventricular out flow tract left ventricular fascicular VT and arrhythmogenic right ventricular 
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dysplasia (ARVD) have also been described12,13. ARVD will be elaborated under the sudden 
death   section   (see   below).                                                                          
Sudden   Death                                                                      
            There has been huge progress in the last few decades in our understanding of familial 
causes of sudden death (SD). The genetic basis of conditions like long QT syndrome, 
hypertrophic cardiomyopathy, Brugada syndrome, catecholaminergic polymorphic VT etc have 
been   elucidated.                                                                                            
Long QT  syndrome                                                                                             
            Since its first description in a  Norwegian family by Jervell and Lange-Nielsen, long QT 
syndrome has been known to be familial14. The first reported kindred had associated deafness 
and was inherited as an autosomal recessive condition. Subsequently, independent reports by 
Romano and Ward described an autosomal dominant type of long QT syndrome15,16. Patients 
with  long QT syndrome present with symptoms of syncope, near-miss sudden death or are 
mistakenly thought to have epilepsy. The key finding is an abnormally prolonged QT interval on 
the ECG. The QTc (using Bazet's formula) usually exceeds 460 ms. Syncope or sudden death 
may be precipitated by exercise or excitement (this predominates in LQT1), sudden fright 
especially from auditory stimuli (predominates in LQT2) or during sleep (dominates LQT3)17,18. 
Schwartz et al have proposed a scoring system to make the diagnosis in atypical cases19.  
            Currently, 10 genetic subtypes of this condition have been described. The three most 
common forms account for about 80% of all described cases and the others have been noted 
mainly in rare families. The genes involved mainly code for either the cardiac potassium channel 
(Long QT1 and 2) or the sodium channel (long QT3). Genetic testing has become commercially 
available in the USA, although the gene mutation is identifiable in only ~60% of patients with 
proven  long QT  syndrome.                                                                                    
            The treatment of long QT syndrome was revolutionized by the arrival of beta blockers. 
From the earliest report, it was clear that epinephrine was detrimental to the heart and could 
precipitate torsade-des-pointes or ventricular fibrillation. Beta blockers have been suggested to 
achieve a ten-fold reduction in the incidence of arrhythmias20. Other therapies shown to help are: 
pacing, left cervical sympathectomy, and in selected cases, mexiletene. The arrival of the 
automatic implantable cardioverter-defibrillator has given us the option of a safety net in patients 
who do not respond to these above treatments.                                                                 
            Infantile LQT is a serious disorder which presents with paroxysms of arrhythmia and 
bradycardia. Both sinus node disease and AV node block have been described. Additional, 
excessive prolongation of the QT interval creates a form of pseudo- AV block whereby every 
other P wave fails to capture the ventricle because the ventricle is refractory21.             
               Recent evidence suggests that with the use of beta-blockers, a very high level of 
protection can be achieved in patients with LQT122. Therefore it is rare for such patients to need 
an ICD. Conversely, there is some evidence that drug therapy is not as protective in LQT3, and 
therefore, an ICD is more beneficial in this group of patients. LQT 2 seems to fall between 1 and 
2 in terms of its risk and the potential need for an ICD.                                                           
Short   QT   syndrome                                                                                    
            More recently, there has been interest in the short QT syndrome where patients often 
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have a QTc of <340 (usually <300 ms)23. So far, three genetic subtypes have been identified. 
Beta-blockers are not protective and may even be detrimental. There is evidence that the class Ia 
antiarrhythmics (quinidine) may be protective in some patients.                              
Hypertrophic   Cardiomyopathy                                                                    
            Hypertrophic Cardiomyopathy (HCM) is a complex disease with a varying phenotype, 
and the result of a multitude of mutations in genes encoding the cardiac contractile proteins 
(actin, myosin, troponin)24,25. Mostly inherited as an autosomal dominant problem, there is wide 
variability in penetrance, and in phenotypic expression. Patients with HCM can have a 
significant incidence of ventricular arrhythmias and SD. There is a rare subtype called Danon 
disease with HCM associated with WPW, which has a high incidence of arrhythmias as well26.
                Certain gene mutations have been identified which are associated with SD in HCM. In 
clinical practice, risk stratification for SD in HCM is a problem. McKenna and colleagues have 
proposed a set of criteria, which should alert the clinician to a high risk of SD27. These include: 
history of near-miss SD, family history of SD, history of syncope, demonstration of non-
sustained VT by ECG monitoring, excessive thickening of the interventricular septum (>3 cm in 
adults), a flat BP profile with exercise. The presence of two of these risk factors should lead to 
intensive evaluation, and the presence of three should be an indication for an ICD.     
Arrhythmogenic  RV   Dysplasia                                                                              
            ARVD is characterized by fibro-fatty infiltration of the myocardium. While the RV is 
predominantly affected, it can also affect the LV. The infiltration leads to islands of myocardium 
separated by the fibro-fatty areas, and the potential for development of areas thinning, aneurysm/
diverticulae formation, akinesia, and most importantly, the development of VT and VF13.     
            The variable phenotype makes this a difficult diagnosis to prove. Ventriculography or 
MRI of the ventricles can help. Biopsy may help if positive, but since this is a spotty disease, can 
be missed by endomyocardial biopsy. Genetic research so far has identified mutations in the 
plakophilin gene as a possible cause of this disease. ARVD is an extremely rare problem in 
children   because   the   phenotype   often   does   not   manifest   itself   until   late   adolescence.  
Brugada syndrome                                                                                               
            Recently described, this syndrome is characterized by sudden death, especially in young 
(teenage/young adult) males, with the ECG finding of ST elevation in the anterior chest leads 
(V1 and V2). The ECG findings can be easily missed or can be intermittent, and therefore, 
special vigilance has been suggested to makes this diagnosis28,29. Brugada syndrome has been 
shown to be caused by certain mutations in the SCN5A gene (the same one responsible for 
LQT3). Sodium channel blockers (such as flecainide/propafenone etc) can be used to unmask the 
problem on the ECG28. Drug therapy has so far not been shown to be effective, and risk 
stratification is also fraught with problems. Presence of the Brugada pattern on ECG, symptoms 
such as syncope, and male sex are thought be indications for the implantation of an ICD29.
Catecholaminergic   Polymorphic   VT                                                                  
           Catecholaminergic Polymorphic VT (CPVT) is a condition characterized by exercise- or 
stress-induced ventricular tachyarrhythmias and syncope, or sudden death, usually in the 
pediatric age group. Familial occurrence is noted in about 30% of cases and inheritance is 
autosomal dominant or recessive, with high penetrance30. Genetic studies have implicated 
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mutations in the cardiac ryanodine receptor gene (RyR2) in autosomal dominant pedigrees, and 
the calsequestrin gene (CASQ2) mutations seen in recessive cases. Additionally, Ankyrin-B 
mutations have also been implicated in this condition. CPVT carries a high mortality in untreated 
cases ranging from 30% to 50% before the age of 20-30 years. While beta-blocker therapy can 
help, the efficacy is low and symptoms have been shown to occur even with a single missed 
dose. Because of this, the trend is to implant a defibrillator.
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